Wealth Effects »

Avadel Pharmaceuticals shares owned by Wealth Effects

Quarter-by-quarter ownership of Avadel Pharmaceuticals (AVDL) shares owned by Wealth Effects from 13F filings

Historical chart of Wealth Effects investment in Avadel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Avadel Pharmaceuticals held by Wealth Effects consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avadel Pharmaceuticals by Wealth Effects

Quarter filed Position value Share count Share price at filing
2024-09-30 $29M 2.2M 13.12
2024-06-30 $32M 2.3M 14.06

More positions owned by Wealth Effects

Avadel Pharmaceuticals Com Shs (AVDL)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
The Trade Desk Com Cl A (TTD)
Alphabet Cap Stk Cl A (GOOGL)
Blackstone Group Inc Com Cl A (BX)
Impinj (PI)
International Business Machines (IBM)
Arrowhead Pharmaceuticals (ARWR)
United Rentals (URI)

View all positions for Wealth Effects

Top funds holding Avadel Pharmaceuticals

Henderson Group
Jeffrey L. Gendell
BlackRock
BlackRock
Vanguard Group
Braidwell
Citadel Advisors
Wealth Effects
Two Seas Capital
Vestal Point Capital
Woodline Partners
Brandes Investment Partners
Tang Capital Management
Geode Capital Management
State Street Corporation

View all funds holding Avadel Pharmaceuticals